#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Idiopathic inflammatory bowel disease and the first type of autoimmune form of pancreatitis: case report


Authors: Tomáš Kupka 1;  Ivo Novotný 2;  Lumír Kunovský 3,4;  Magdalena Uvírová 5;  Martin Blaho 1;  Jana Dvořáčková 6;  Petr Dítě 1
Authors‘ workplace: Interní klinika LF OU a FN Ostrava 1;  Oddělení gastroenterologie Masarykova onkologického stavu, Brno 2;  Interní gastroenterologická klinika LF MU a FN Brno, pracoviště Bohunice 3;  Chirurgická klinika LF MU a FN Brno, pracoviště Bohunice 4;  CGB laboratoř a. s., Ostrava 5;  Ústav patologie LF OU a FN Ostrava 6
Published in: Vnitř Lék 2019; 65(7-8): 520-523
Category: Case reports

Overview

The autoimmune form of pancreatitis (AIP) is divided into the following two subtypes. The 1st subtype is characterized by the high presence of immunoglobulin G4 in the blood serum and tissue of some organs which are in the close connection to the so called IgG4 associated disorders. The typical diagnostic signs of AIP are the histomorphological changes. This type of AIP is more frequent than the 2nd type with which has however some common histomorphological signs and mainly the positive response to the administered steroids used in the initial treatment. Whilst the 1st type of AIP is typically connected to the disorders of various organs such are the biliary tract, salivary and lacrimal glands, retroperitoneal fibrosis, reins, prostate gland and the next ones, the 2nd type of AIP is significantly connected to the inflammatory bowel disease only. Inflammatory bowel diseases are rarely present in the 1st type of AIP on the contrary. In our case report we mention the first published observations performed in the Czech Republic when the 1st type of AIP is succeeded by the inflammatory bowel disease – Crohn´s disease.

Keywords:

autoimmune pancreatitis – immunoglobulin G4 – immunoglobulin G4 associated disorders – inflammatory bowel disease


Sources
  1. Chapin LE, Scudamore HH, Baggenstoss AH et al. Regional enteritis: associated visceral changes. Gastroenterology 1956; 30: 404–415.
  2. Yoshida K, Toki F, Takeuchi T et al. Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40: 1561–1568. Dostupné z DOI: <http://doi: 10.1007/bf02285209>.
  3. Hamano H, Kawa S, Horiuchi A et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344(10): 732–738. Dostupné z DOI: <http://doi 10.1056/NEJM200103083441005>.
  4. Shimosegawa T, Chari ST, Frulloni ST et al. International consensus diagnostic criteria for autoimmune pancreatitis. Guidelines of the International Association of Pancreatology. Pancreas 2011; 40(3): 352–358. Dostupné z DOI: <http://doi 10.1097/MPA.0b013e3182142fd2>.
  5. Finkelberg DL, Sahani D, Deshpande V et al. Autoimmune pancreatitis. N Engl J Med 2006; 355(25): 2670–2676. Dostupné z DOI: <http://doi 10.1056/NEJMra061200>.
  6. Maire F, LeBaleur Y, Rebours V et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 2011; 106(1): 151–156. Dostupné z DOI: <http://doi 10.1038/ajg.2010.314>.
  7. Dítě P, Trna J, Kinkor Z et al. Unusual multiorgan immunoglobulin G4 in inflammation: Autoimmune pancreatitis, Mikulicz syndrom and IgG4 mastitis. Gut Liver 2013; 7(5): 621–624. Dostupné z DOI: <http://doi 10.5009/gnl.2013.7.5.621>.
  8. Kamiswa T, Notohara K, Shimosegawa T. Two clinopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology 2010; 139(1): 22–5. Dostupné z DOI: <http://doi 10.1053/j.gastro.2010.05.019>.
  9. Hart PA, Zen Y, Chari T. Recent advances in autoimmune pancreatitis. Gastroenterology 2015; 149(1): 39–51. Dostupné z DOI: <http://doi 10.1053/j.gastro.2015.03.010>.
  10. Barthet M, Hastier P, Bernard CP et al. Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am Gastroenterol 1999; 94(8): 2141–2148. Dostupné z DOI: <http://doi 10.1111/j.1572–0241.1999.01287.x>.
  11. Kawa S, Okazaki K, Notohara K et al. Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis. J Gastroenterol 2015; 50(7): 805–815. Dostupné z DOI: <http://doi 10.1007/s00535–014–1012–5>.
  12. Lorenzo D, Maire F, Stefanescu C et al. Features of autoimmune pancreatitis associated with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2018; 16(1): 59–67. Dostupné z DOI: <http://doi 10.1016/j.cgh.2017.07.033>.
  13. Ott C, Scholmerich J. Extraintestinal manifestations and complications in BD. Nat Rev Gastroent Hepatol 2013; 10(10): 585–595. Dostupné z DOI: <http://doi 10.1038/nrgastro.2013.117>.
  14. Ueki T, Kawamoto K, Otsuka Y et al. Prevalence and clinicopathological features of autoimmune pancreatitis in Japanese patients with inflammatory bowel disease. Pancreas 2015; 44(3): 434–440. Dostupné z DOI: <http://doi 10.1097/MPA.0000000000000261>.
  15. Ramos LR, Sachar DB, DiMaio CJ et al. Inflammatory bowel disease and pancreatitis: a review. J Crohns Colitis 2016 ;10(1): 95–104. Dostupné z DOI: <http://doi 10.1093/ecco-jcc/jjv153>.
  16. Angelini G, Cavallini G, Bovo P et al. Pancreatic function in chronic inflammatory bowel disease. Int J Pancreatol 1988; 3(2–3): 185–193. Dostupné z DOI: <http://doi 10.1007/BF02798930>.
  17. Heikius B, Niemela S, Lehtola J et al. Pancreatic duct abnormalites and pancreatic function in patients with chronic inflammatory bowel disease. Scand J Gatroent 1996; 31(5): 517–523. Dostupné z DOI: <http://doi 10.3109/00365529609006775>.
  18. Hart PA, Zen Y, Chari T. Recent advances in autoimmune pancreatitis. Gastroenterology 2015; 149(1): 39–51. Dostupné z DOI: <http://doi 10.1053/j.gastro.2015.03.010>.
Labels
Diabetology Endocrinology Internal medicine
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#